Analyst Ratings For bluebird bio (NASDAQ:BLUE)
Today, Cantor Fitzgerald reiterated its Sell rating on bluebird bio (NASDAQ:BLUE) with a price target of $39.00.
There are 2 sell ratings, 4 hold ratings, 11 buy ratings on the stock.
The current consensus rating on bluebird bio (NASDAQ:BLUE) is Buy (Score: 2.53) with a consensus target price of $98.82 per share, a potential 2.88% upside.
Some recent analyst ratings include
- 7/24/2017-Cantor Fitzgerald Reiterated Rating of Sell.
- 7/10/2017-Morgan Stanley Reiterated Rating of Equal Weight.
- 7/6/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 6/30/2017-BTIG Research was Downgraded by analysts at BTIG Research from a “Buy ” rating to a ” Neutral” rating. They now have a $108.25 price target on the stock, up previously from $37.05 .
- 6/23/2017-Cowen and Company Reiterated Rating of Buy.
- 6/23/2017-Wedbush Reiterated Rating of Outperform.
- On 7/10/2017 Jeffrey T Walsh, Insider, sold 2,500 with an average share price of $99.89 per share and the total transaction amounting to $249,725.00. View SEC Filing
- On 7/7/2017 David Davidson, Insider, sold 1,200 with an average share price of $100.49 per share and the total transaction amounting to $120,588.00. View SEC Filing
- On 7/6/2017 Philip D Gregory, Insider, sold 2,250 with an average share price of $103.83 per share and the total transaction amounting to $233,617.50. View SEC Filing
- On 7/5/2017 David Davidson, Insider, sold 5,000 with an average share price of $105.28 per share and the total transaction amounting to $526,400.00. View SEC Filing
- On 6/29/2017 Eric Sullivan, Insider, sold 6,787 with an average share price of $108.96 per share and the total transaction amounting to $739,511.52. View SEC Filing
- On 6/27/2017 Nick Leschly, Insider, sold 25,000 with an average share price of $108.05 per share and the total transaction amounting to $2,701,250.00. View SEC Filing
- On 6/23/2017 Daniel Lynch, Director, sold 4,000 with an average share price of $109.09 per share and the total transaction amounting to $436,360.00. View SEC Filing
Recent Trading Activity for bluebird bio (NASDAQ:BLUE)
Shares of bluebird bio closed the previous trading session at 96.35 up +0.30 0.31% with 426,101 shares trading hands.